Europe Preimplantation Genetic Testing Market Size & Outlook

The preimplantation genetic testing market in Europe is expected to reach a projected revenue of US$ 437.7 million by 2030. A compound annual growth rate of 6.7% is expected of Europe preimplantation genetic testing market from 2024 to 2030.
Revenue, 2023 (US$M)
$278.1
Forecast, 2030 (US$M)
$437.7
CAGR, 2024 - 2030
6.7%
Report Coverage
Europe

Europe preimplantation genetic testing market, 2018-2030 (US$M)

Europe

Related Markets

Europe preimplantation genetic testing market highlights

  • The Europe preimplantation genetic testing market generated a revenue of USD 278.1 million in 2023.
  • The market is expected to grow at a CAGR of 6.7% from 2024 to 2030.
  • In terms of segment, pgd was the largest revenue generating procedure type in 2023.
  • PGD is the most lucrative procedure type segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.


Europe data book summary

Market revenue in 2023USD 278.1 million
Market revenue in 2030USD 437.7 million
Growth rate6.7% (CAGR from 2023 to 2030)
Largest segmentPgd
Fastest growing segmentPGD
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPGD, PGS
Key market players worldwideQuest Diagnostics Inc, Natera Inc, The Cooper Companies Inc, Invitae Corp, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Illumina Inc, Vitrolife AB ADR, Roche Holding AG, Genea Biomedx, Bioarray


Other key industry trends

  • In terms of revenue, Europe region accounted for 34.7% of the global preimplantation genetic testing market in 2023.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 439.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Preimplantation Genetic Testing Market Companies

Name Profile # Employees HQ Website

Europe preimplantation genetic testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to preimplantation genetic testing market will help companies and investors design strategic landscapes.


Pgd was the largest segment with a revenue share of 77.09% in 2023. Horizon Databook has segmented the Europe preimplantation genetic testing market based on pgd, pgs covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe preimplantation genetic testing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe preimplantation genetic testing market databook

  • Our clientele includes a mix of preimplantation genetic testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe preimplantation genetic testing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe preimplantation genetic testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe preimplantation genetic testing market outlook size, by country, 2018-2030 (US$M)

Europe Preimplantation Genetic Testing Market Outlook Share, 2023 & 2030 (US$M)

Europe preimplantation genetic testing market outlook size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more